BioSpace News Archive

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended December 29, 2019.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the fourth quarter and year ended December 31, 2019, on Monday, February 10, 2020 at 6:00 a.m. ET, followed by a live conference call and webcast to discuss these financial results at 8:30 AM ET.

The rare genetic disease CDKL5 Deficiency Disorder (CDD) has been designated with a new disease code in the International Classification of Diseases (ICD), the medical classification list from the World Health Organization (WHO).

Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it has executed a definitive agreement with the University of Geneva for an exclusive global license to a novel drug discovery platform for the generation of G protein coupled receptor (GPCR) chemokine analogs.

Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that the Biomedical Advanced Research and Development Authority (‘BARDA’) has expanded its award for the clinical and regulatory development of Summit’s precision antibiotic ridinilazole for the treatment of C. difficile infection (‘CDI’) by $8.8 million.

Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers

Kerrisdale Capital, a private investment manager, has published a report explaining its short position in Principia Biopharma Inc. (NASDAQ: PRNB), a biopharmaceutical company whose $2 billion valuation is driven by misleading clinical data and an ineffective strategy of treating autoimmune diseases with BTK inhibitors

Medical Group Management Association (MGMA) and Jackson Physician Search, a firm specializing in the permanent recruitment of physicians, physician leaders and advanced practice providers throughout the U.S., today announced a new executive partnership designed to help medical practices operate more efficiently, while providing optimal levels of care.

CareMount Medical announced today its Next Generation Accountable Care Organization (Next Generation ACO), CareMount Health Solutions ACO, LLC, generated $778,583 in shared savings for the Performance Year 2018 for The Centers for Medicare & Medicaid Services’ (CMS’) Next Generation ACO Model initiative

Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer’s disease, depression, and even asthma.